GU Oncology Now

covid-19, Hydroxychloroquine, Secukinumab, interview, rheumatologists, rheumatologist, arthroplasty, arthritis, rheumatic, ixekizumab, RA, rheumatoid, FDA, Rheum Round-up: Five RA Drugs Compared, Two THA Approaches, and more

Rheum Round-up: Hydroxychloroquine, Arthritis and Alcohol, and more

January 15, 2021

In this week’s rheumatology round-up, read about the latest updates on hydroxychloroquine and two arthritis drugs (tentatively) deemed effective...

MRI Often Underestimates the Size of Tumors in Prostate Cancer

January 8, 2021

Worried senior man on a visit to supportive doctor.

ADT-Related Inflammation May Cause Fatigue in Patients with Prostate Cancer

January 5, 2021

Hispanic Ethnicity, Medicaid Decrease Odds of Active Surveillance in Low-risk Prostate Cancer

Hispanic Ethnicity, Medicaid Decrease Odds of Active Surveillance in Low-risk Prostate Cancer

December 29, 2020

Timely Treatment for Common Cancers May Be Associated with Mortality

Timely Treatment for Common Cancers May Be Associated with Mortality

December 15, 2020

How Long Can Surgery for High-Risk Prostate Cancer Be Safely Delayed?

December 9, 2020

brain, machine, cancer, prostate, oncology, cancer, hematology, hem/onc, roundup, aspirin

Hem/Onc Roundup: Severe Flu Risk Persists Years After Cancer Diagnosis, and more

December 4, 2020

Study Shows How Radiation Therapy Impacts Cancer Patient Finances

November 30, 2020

Researchers Propose A New Validated Prostate Cancer Staging System

CRYM Protein Expression Linked to Tumor Growth and Prognosis in Prostate Cancer

November 23, 2020

Curated Journal reading List

Differential DNA Methylation in Prostate Tumors from Puerto Rican Men

January 16, 2021

Differential DNA Methylation in Prostate Tumors from Puerto Rican Men

January 16, 2021

Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis

January 16, 2021

Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis

January 16, 2021

Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line

January 16, 2021

Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line

January 16, 2021

Advertisement

Expert Interviews

ASH 2020: Outcomes from the CARTITUDE-1 Study Assessing CAR T-Cell Therapy...

December 9, 2020

ASH 2020: GPRC5D Is a New Target of Interest for Multiple...

December 9, 2020

How Racial Disparity and COVID-19 Affect Prostate Cancer Research, with Scott...

December 1, 2020